Assessing Mitochondrial Toxicity in Early Drug Development

Mitochondrial toxicity assessments are crucial to ensuring the safety and efficacy of candidate compounds during drug development. 

However, the pharmaceutical industry needs more stringent approaches to screening than current assays provide.

This case study highlights a novel assay platform that examines mitochondrial health with more sensitivity, speed and efficacy.

Download this case study to discover: 

•  The importance of mitochondrial toxicity testing
  
• Real-time assays that offer unparalleled sensitivity and mechanistic insights 
• Toxic compound screening methods that save time, money and reduce risk